Previous investigations involving breast cancer, HCC and cervical carcinoma demonstrated that FUNDC2 participated in cancers, supporting our findings that FUNDC2 also was involved in pan-cancer [6]. This evidence concerns the gene FUNDC2 and breast carcinoma.